HK1022175A1 - Human toll-like receptor proteins, related reagents and methods - Google Patents

Human toll-like receptor proteins, related reagents and methods

Info

Publication number
HK1022175A1
HK1022175A1 HK00101136A HK00101136A HK1022175A1 HK 1022175 A1 HK1022175 A1 HK 1022175A1 HK 00101136 A HK00101136 A HK 00101136A HK 00101136 A HK00101136 A HK 00101136A HK 1022175 A1 HK1022175 A1 HK 1022175A1
Authority
HK
Hong Kong
Prior art keywords
methods
receptor proteins
receptors
related reagents
human toll
Prior art date
Application number
HK00101136A
Other languages
English (en)
Inventor
Gerard T Hardiman
Fernando L Rock
J Fernando Bazan
Robert A Kastelein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27366459&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1022175(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1022175A1 publication Critical patent/HK1022175A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK00101136A 1997-05-07 2000-02-25 Human toll-like receptor proteins, related reagents and methods HK1022175A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4429397P 1997-05-07 1997-05-07
US7221298P 1998-01-22 1998-01-22
US7694798P 1998-03-05 1998-03-05
PCT/US1998/008979 WO1998050547A2 (fr) 1997-05-07 1998-05-07 Recepteur proteique humain du type toll, reactifs connexes et techniques afferentes

Publications (1)

Publication Number Publication Date
HK1022175A1 true HK1022175A1 (en) 2000-07-28

Family

ID=27366459

Family Applications (3)

Application Number Title Priority Date Filing Date
HK00101136A HK1022175A1 (en) 1997-05-07 2000-02-25 Human toll-like receptor proteins, related reagents and methods
HK08106460.0A HK1112018A1 (en) 1997-05-07 2007-10-11 Human toll-like receptor proteins, related reagents and methods
HK07111049.1A HK1102720A1 (en) 1997-05-07 2007-10-11 Human toll-like receptor proteins, related reagents and methods

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK08106460.0A HK1112018A1 (en) 1997-05-07 2007-10-11 Human toll-like receptor proteins, related reagents and methods
HK07111049.1A HK1102720A1 (en) 1997-05-07 2007-10-11 Human toll-like receptor proteins, related reagents and methods

Country Status (20)

Country Link
EP (4) EP1925666B1 (fr)
JP (4) JP2002514083A (fr)
KR (1) KR100388860B1 (fr)
CN (4) CN1800214A (fr)
AT (3) ATE458053T1 (fr)
AU (1) AU740333B2 (fr)
CA (1) CA2289912C (fr)
CY (1) CY1109645T1 (fr)
DE (3) DE69841514D1 (fr)
DK (2) DK0980429T3 (fr)
ES (3) ES2331622T3 (fr)
HK (3) HK1022175A1 (fr)
ID (1) ID28299A (fr)
IL (1) IL132614A0 (fr)
NO (1) NO995458D0 (fr)
NZ (1) NZ338073A (fr)
PL (1) PL336635A1 (fr)
PT (1) PT1798288E (fr)
SK (1) SK146599A3 (fr)
WO (1) WO1998050547A2 (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US7696327B1 (en) 1997-10-17 2010-04-13 Genentech, Inc. Antibodies to human Toll homologues
US20030032090A1 (en) 1997-05-07 2003-02-13 Schering Corporation, A New Jersey Corporation Human receptor proteins; related reagents and methods
PT1887014E (pt) * 1997-10-17 2010-07-05 Genentech Inc Homëlogos de toll humana
AU2003203679B2 (en) * 1997-10-17 2007-04-05 Genentech, Inc. Human toll homologues
JP2000128900A (ja) * 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6740487B1 (en) 1999-06-10 2004-05-25 University Of Iowa Research Foundation Variant TLR4 nucleic acid and uses thereof
EP1226252A2 (fr) * 1999-11-02 2002-07-31 Chiron Corporation DETECTEURS DES RECEPTEURS D'ARN DOUBLE BRIN (dsRNA-R) ET PROCEDES CORRESPONDANTS
GB9927332D0 (en) * 1999-11-18 2000-01-12 Leiv Eiriksson Nyfotek As Novel antibody and uses thereof
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
EP1283849A2 (fr) * 2000-05-25 2003-02-19 Schering Corporation Proteines receptrices humaines, reactifs et methodes associes
CA2407910C (fr) 2000-06-16 2013-03-12 Steven M. Ruben Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
JP2002034565A (ja) * 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
JP2004532604A (ja) 2000-08-18 2004-10-28 ダイアックス コーポレーション Ｂリンパ球刺激因子タンパク質（ＢＬｙＳ）のための結合性ポリペプチド
US20030091565A1 (en) * 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
ATE510850T1 (de) 2000-09-15 2011-06-15 Coley Pharm Gmbh Verfahren zum hochdurchsatzscreening von auf cpg basierenden immunagonisten und -antagonisten
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
IL160837A0 (en) * 2001-10-05 2004-08-31 Coley Pharm Gmbh Toll-like receptor 3 signaling agonists and antagonists
JP2005513021A (ja) * 2001-11-16 2005-05-12 スリーエム イノベイティブ プロパティズ カンパニー Ｉｒｍ化合物およびトール様受容体経路に関する方法および組成物
GB0127618D0 (en) * 2001-11-17 2002-01-09 Univ Nottingham "Composition and method for treatment of wounds"
JP2004016021A (ja) 2002-06-12 2004-01-22 Japan Science & Technology Corp 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット
WO2004053452A2 (fr) * 2002-12-11 2004-06-24 3M Innovative Properties Company Analyses relatives a l'activite du recepteur de type toll
WO2004094671A2 (fr) * 2003-04-22 2004-11-04 Coley Pharmaceutical Gmbh Procedes et produits pour identifier et evaluer des ligands des tlr
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
TW200516153A (en) * 2003-10-03 2005-05-16 Hitachi Chemical Co Ltd Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same
TW200514850A (en) * 2003-10-03 2005-05-01 Hitachi Chemical Co Ltd Method of evaluating risk for viral infection
EP1697389A4 (fr) 2003-10-24 2008-12-24 Eisai R&D Man Co Ltd Composes et methodes permettant de traiter les maladies et etats pathologiques lies au recepteur 2 de type toll
WO2005051317A2 (fr) 2003-11-25 2005-06-09 3M Innovative Properties Company Systèmes cycliques d'imidazo substitués et procédés
JP2008022701A (ja) * 2004-09-24 2008-02-07 Japan Science & Technology Agency 可溶型Ｔｏｌｌ様受容体４タンパク質
WO2006054129A1 (fr) 2004-11-19 2006-05-26 Institut Gustave Roussy Traitement ameliore du cancer par arn double brin
AR051836A1 (es) 2004-11-30 2007-02-14 Centocor Inc Antagonistas de receptor 3 simil toll metodos y usos
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US7498409B2 (en) 2005-03-24 2009-03-03 Schering Corporation Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
US7700728B2 (en) 2005-03-24 2010-04-20 Schering Corporation Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
ES2435775T3 (es) 2005-10-27 2013-12-23 Janssen Biotech, Inc. Moduladores de receptor tipo Toll 3, procedimientos y usos
AU2007224034B2 (en) 2006-03-07 2012-03-29 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2007123765A2 (fr) 2006-03-31 2007-11-01 Human Genome Sciences Inc. NEUTROKINE-ALPHA et variant d'epissage de la neutrokine-alpha
CN101134046B (zh) * 2006-09-01 2011-10-05 中国医学科学院药物研究所 Tlr4和tlr9激动剂复方在抑制肿瘤转移中的应用
JP2010527633A (ja) * 2007-05-25 2010-08-19 セントコア・オーソ・バイオテツク・インコーポレーテツド Ｔｏｌｌ様受容体３モジュレーター及びその使用
US20110076296A1 (en) 2008-04-25 2011-03-31 Innate Pharma S.A. TLR3 Agonist Compositions
EP2116602A1 (fr) 2008-05-07 2009-11-11 Institut Gustave Roussy Combinaison de produits pour traiter le cancer
EP2334703B1 (fr) 2008-09-17 2015-07-08 Innate Pharma Compositions et procédés pour détecter tlr3
EP2328911A4 (fr) 2008-09-22 2012-03-14 Cedars Sinai Medical Center Md-2 humaine sous sa forme courte utilisée comme régulateur négatif de la signalisation par le récepteur de type toll-4
US9512196B2 (en) 2008-09-22 2016-12-06 Cedars-Sinai Medical Center Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
EP2451844B1 (fr) 2009-07-10 2015-04-22 Innate Pharma Agents de liaison à tlr3
WO2011021524A1 (fr) * 2009-08-19 2011-02-24 国立大学法人名古屋大学 Peptides induisant la propriété adhésive d'une bactérie de l'acide lactique et leur utilisation
AU2011281192A1 (en) 2010-07-19 2013-02-28 Yeda Research And Development Co. Ltd. Peptides based on the transmembrane domain of a Toll-like receptor (TLR) for treatment of TLR-mediated diseases
WO2012088272A1 (fr) 2010-12-21 2012-06-28 Duke University Procédés et compositions combinant une immunothérapie à une activation de monocytes
CA2824313A1 (fr) 2011-01-12 2012-07-19 Innate Pharma Agents de liaison a tlr3
US9353115B2 (en) 2011-06-01 2016-05-31 Janus Biotherapeutics, Inc. Immune system modulators
EP2713736B1 (fr) 2011-06-01 2023-08-02 Janus Biotherapeutics, Inc. Nouveaux modulateurs du système immunitaire
IN2014KN00948A (fr) 2011-10-04 2015-08-21 Janus Biotherapeutics Inc
EP2766384B1 (fr) * 2011-10-10 2016-11-23 Yeda Research and Development Co. Ltd. Peptides agonistes du récepteur de type toll-4 (tlr-4) pour la modulation de la réponse immunitaire déclenchée par le tlr-4
US9944712B2 (en) 2012-05-31 2018-04-17 Innate Pharma TLR3 binding agents
US10017739B2 (en) 2012-09-06 2018-07-10 Duke University Methods of expanding and assessing B cells and using expanded B cells to treat disease
CN113502299B (zh) * 2021-07-20 2023-03-14 中国农业大学 一种抗金黄色葡萄球菌遗传修饰山羊生产方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
WO1998002557A2 (fr) * 1996-07-12 1998-01-22 Schering Corporation Fnt-alpha convertase mammalienne
DK1000146T3 (da) * 1997-08-01 2007-01-08 Serono Genetics Inst Sa 5' EST'er for non-vævsspecifikke secernerede proteiner
PT1887014E (pt) * 1997-10-17 2010-07-05 Genentech Inc Homëlogos de toll humana

Also Published As

Publication number Publication date
EP1798288A3 (fr) 2007-09-12
DK0980429T3 (da) 2007-04-10
PT1798288E (pt) 2009-12-23
ID28299A (id) 2001-05-10
CN1935840A (zh) 2007-03-28
DE69841170D1 (de) 2009-10-29
EP1988166A1 (fr) 2008-11-05
WO1998050547A2 (fr) 1998-11-12
ATE348157T1 (de) 2007-01-15
DK1798288T3 (da) 2010-01-04
ATE443139T1 (de) 2009-10-15
ES2331622T3 (es) 2010-01-11
ES2340210T3 (es) 2010-05-31
NO995458L (no) 1999-11-08
AU7175498A (en) 1998-11-27
EP0980429A2 (fr) 2000-02-23
HK1102720A1 (en) 2007-12-07
KR100388860B1 (ko) 2003-06-25
DE69841514D1 (de) 2010-04-01
JP2005120106A (ja) 2005-05-12
PL336635A1 (en) 2000-07-03
EP1798288B1 (fr) 2009-09-16
CN101486759A (zh) 2009-07-22
EP0980429B1 (fr) 2006-12-13
CN1263555A (zh) 2000-08-16
SK146599A3 (en) 2000-07-11
AU740333B2 (en) 2001-11-01
IL132614A0 (en) 2001-03-19
ES2279572T3 (es) 2007-08-16
CY1109645T1 (el) 2012-05-23
CN1225555C (zh) 2005-11-02
CN1800214A (zh) 2006-07-12
DE69836630T2 (de) 2007-10-11
NO995458D0 (no) 1999-11-08
EP1925666A1 (fr) 2008-05-28
CA2289912A1 (fr) 1998-11-12
JP2002514083A (ja) 2002-05-14
DE69836630D1 (de) 2007-01-25
CA2289912C (fr) 2011-07-26
JP2009089713A (ja) 2009-04-30
HK1112018A1 (en) 2008-08-22
ATE458053T1 (de) 2010-03-15
JP2006052232A (ja) 2006-02-23
EP1925666B1 (fr) 2010-02-17
EP1798288A2 (fr) 2007-06-20
WO1998050547A3 (fr) 1999-03-11
NZ338073A (en) 2001-09-28
KR20010012323A (ko) 2001-02-15

Similar Documents

Publication Publication Date Title
HK1102720A1 (en) Human toll-like receptor proteins, related reagents and methods
HK1049862A1 (en) Mammalian cytokine receptor subunit proteins, related reagents and methods
WO1998031799A3 (fr) Polynucleotides et polypeptides codant des recepteurs
AU2001294541A1 (en) Mammalian genes; related reagents and methods
EP1908837A3 (fr) Protéines humaines réceptrices, réactifs associés et procédés
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
ATE295423T1 (de) Phosphodiesterase 8
WO1996021734A3 (fr) Antigenes p15 et tyrosinase du melanome et leur utilisation dans des procedes diagnostiques et therapeutiques
WO1999046379A3 (fr) Proteines receptrices humaines; reactifs et procedes associes
CA2185112A1 (fr) Anticorps monoclonaux humanises contre l'interleukine-4 chez l'homme
WO1998041538A3 (fr) Nouvelle proteine receptrice des cytokines/steroides humaine
BR9808747A (pt) Proteìnas receptoras humanas; reagentes relacionados e métodos
ATE99061T1 (de) Monoklonale human-antikoerper, spezifisch fuer rh(d).

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110507